Our Mission:
Empowering the global advancement of innovative biopharmaceutical programs through science-driven strategic collaboration and international business development support. Through our collaboration with Angine Biotech and a growing global network of innovators, we help identify promising therapeutic opportunities and facilitate strategic partnerships with leading international organizations.
Our Services:
Licensing-In & Opportunity Sourcing
- Identification of innovative therapeutic opportunities worldwide
- Scientific and commercial evaluation of external assets
- Partner selection and transaction support
Licensing-Out & Global Partnering
- Strategic positioning of clinical-stage programs
- Global partner identification and engagement
- Cross-border licensing and collaboration support
Strategic Collaboration & BD Advisory
- Scientific communication and asset positioning
- Non-confidential presentation development
- International partnering coordination
Selected Collaboration Highlights
Licensing-In & Commercialization Highlights
- Bijuva® — Supported cross-border business development activities contributing to the successful introduction of Bijuva® into Greater China.
- Inbrija® — Supported strategic collaboration activities related to licensing and commercialization opportunities in Greater China.
Licensing-Out & Strategic Partnering
- B1344 — Long-acting FGF21 biologic program for metabolic and MASH-related diseases
- VDJ001 — Anti-IL-6R monoclonal antibody program for immunology and CKD-associated anemia
- SC1011 — Anti-fibrotic small molecule program for IPF and tissue repair applications
Recent Collaboration Highlights
May 2026 — Inbrija® Licensing-In Collaboration
- Supported strategic business development activities contributing to the successful licensing of Inbrija® for Greater China.
- The collaboration involved scientific evaluation, partner engagement, and cross-border transaction support between international innovators and Chinese pharmaceutical partners.
- Read the Official Collaboration Announcement
May 2025 — Bijuva® Licensing-In Collaboration
- Supported cross-border business development activities contributing to the successful licensing and commercialization of Bijuva® in Greater China. The collaboration involved opportunity identification, scientific evaluation, partner engagement, and transaction support between Theramex and Jincheng Pharmaceutical.
- Read the Official Collaboration Announcement
Partnered with:
Angine Biotech Co., Ltd, based in Hangzhou, China, facilitates international project transfers for the biopharmaceutical industry. They collaborate with overseas enterprises, research institutions, and investment banks, specializing in cross-border cooperation related to drugs, medical devices, and health products.
Visit their website!